Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
出版年份 2021 全文链接
标题
Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
作者
关键词
-
出版物
World Journal of Surgical Oncology
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-18
DOI
10.1186/s12957-021-02393-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Correlation between hypoxia-inducible factor-1α C1772T/G1790A polymorphisms and head and neck cancer risk: a meta-analysis
- (2021) Ting Wu et al. World Journal of Surgical Oncology
- Capecitabine for the treatment of pancreatic cancer
- (2019) Nauman S. Siddiqui et al. EXPERT OPINION ON PHARMACOTHERAPY
- Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
- (2019) John N Primrose et al. LANCET ONCOLOGY
- Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
- (2019) Zhimin Ye et al. World Journal of Surgical Oncology
- Future of Radiotherapy in Nasopharyngeal Carcinoma
- (2019) Xue-Song Sun et al. BRITISH JOURNAL OF RADIOLOGY
- Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinoma
- (2019) Yuan Zhang et al. Cancer Communications
- Nasopharyngeal carcinoma
- (2018) Prosenjit Paul et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- The role of nasopharyngeal examination and biopsy in the diagnosis of malignant diseases
- (2018) Necmi Arslan et al. Brazilian Journal of Otorhinolaryngology
- MMP-2: Is too low as bad as too high in the cardiovascular system?
- (2018) Eugenio Hardy et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors
- (2018) Bernd Beutel et al. BIOCONJUGATE CHEMISTRY
- EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways
- (2018) Cheng Lin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- m6A-mediated ZNF750 repression facilitates nasopharyngeal carcinoma progression
- (2018) Panpan Zhang et al. Cell Death & Disease
- Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?
- (2018) Victor H. Lee et al. Journal of Oncology Practice
- Capecitabine in early breast cancer: A meta-analysis of randomised controlled trials
- (2017) Akina Natori et al. EUROPEAN JOURNAL OF CANCER
- A Systematic Review of Strategies to Prevent Cisplatin‐Induced Nephrotoxicity
- (2017) Daniel J. Crona et al. ONCOLOGIST
- Impact of the Karnofsky Performance Status on Survival and its Dynamics During the Terminal Year of Peritoneal Dialysis Patients
- (2017) Ana Paula Modesto et al. PERITONEAL DIALYSIS INTERNATIONAL
- Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
- (2017) Juming Yan et al. Cold Spring Harbor Perspectives in Biology
- Possible Pathways of Capecitabine-Induced Hand–Foot Syndrome
- (2016) Yan Lou et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Capecitabine for treating head and neck cancer
- (2016) Hassan Iqbal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma after primary radiotherapy: options of surgical methods and regions
- (2016) Sheng-ye Wang et al. World Journal of Surgical Oncology
- Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
- (2015) Se Hoon Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
- (2014) Hans-Joachim Schmoll et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now